Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state

$7.1M USD

Funder NATIONAL CANCER INSTITUTE
Recipient Organization Dana-Farber Cancer Inst
Country United States
Start Date Apr 01, 2021
End Date Mar 31, 2026
Duration 1,825 days
Number of Grantees 2
Roles Principal Investigator; Co-Investigator
Data Source NIH (US)
Grant ID 10184885
Grant Description

PROJECT SUMMARY Recent whole-exome sequencing studies in human cancer and neurodevelopmental disorders have unmasked frequent mutations in genes encoding chromatin regulatory proteins.

Specifically, genes encoding subunits of the mammalian SWI/SNF ATP-dependent chromatin remodeling complexes (also called mSWI/SNF or BAF complexes) are perturbed in over 20% of malignancies, underscoring their critical roles in the maintenance of timely and appropriate gene expression.

The mechanisms by which mSWI/SNF family complexes are targeted on chromatin and the features of the histone landscape that govern their activities remain unknown.

Indeed, a systematic evaluation defining the contributions of specific histone landscape features to canonical BAF, PBAF, and non-canonical BAF complex targeting and activity would represent a significant advancement in the field at- large.

Here we aim to: (1) Determine the genome-wide targeting of distinct, final-form mSWI/SNF complexes in human cells and the impact of select cancer-associated complex perturbations; (2) Define the in vitro nucleosome remodeling and ATPase activities of endogenously-purified mSWI/SNF subcomplexes, BAF, PBAF, and ncBAF, in wild-type (WT) and mutant states; and (3) Determine the impact of core histone variants and histone tail modifications on mSWI/SNF complex nucleosome binding and activity.

Taken together, successful completion of these aims centered at the intersection of biochemistry, epigenetics, and cancer biology, will constitute a highly timely series of advances in the field of chromatin biology, and will contribute important knowledge regarding the mechanism of targeting of mSWI/SNF complexes across a range of both normal and oncogenic states.

Given that a major impediment to the development of on-target modulatory agents of mSWI/SNF complexes lies in the lack of biological understanding of complex-specific targeting and functional regulation, the results of this proposal are likely to provide the basis for new approaches toward targeted disruption of mSWI/SNF-chromatin interactions.

All Grantees

Dana-Farber Cancer Inst

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant